These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25052160)
1. Prostacyclin influences the pressure reactivity in patients with severe traumatic brain injury treated with an ICP-targeted therapy. Koskinen LO; Eklund A; Sundström N; Olivecrona M Neurocrit Care; 2015 Feb; 22(1):26-33. PubMed ID: 25052160 [TBL] [Abstract][Full Text] [Related]
2. Prostacyclin Affects the Relation Between Brain Interstitial Glycerol and Cerebrovascular Pressure Reactivity in Severe Traumatic Brain Injury. Koskinen LD; Sundström N; Hägglund L; Eklund A; Olivecrona M Neurocrit Care; 2019 Dec; 31(3):494-500. PubMed ID: 31123992 [TBL] [Abstract][Full Text] [Related]
3. Prostacyclin treatment and clinical outcome in severe traumatic brain injury patients managed with an ICP-targeted therapy: a prospective study. Olivecrona M; Rodling-Wahlström M; Naredi S; Koskinen LO Brain Inj; 2012; 26(1):67-75. PubMed ID: 22149445 [TBL] [Abstract][Full Text] [Related]
4. Prostacyclin treatment in severe traumatic brain injury: a microdialysis and outcome study. Olivecrona M; Rodling-Wahlström M; Naredi S; Koskinen LO J Neurotrauma; 2009 Aug; 26(8):1251-62. PubMed ID: 19226191 [TBL] [Abstract][Full Text] [Related]
5. Pressure reactivity as a guide in the treatment of cerebral perfusion pressure in patients with brain trauma. Howells T; Elf K; Jones PA; Ronne-Engström E; Piper I; Nilsson P; Andrews P; Enblad P J Neurosurg; 2005 Feb; 102(2):311-7. PubMed ID: 15739560 [TBL] [Abstract][Full Text] [Related]
6. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group. Marmarou A; Nichols J; Burgess J; Newell D; Troha J; Burnham D; Pitts L J Neurotrauma; 1999 Jun; 16(6):431-44. PubMed ID: 10391361 [TBL] [Abstract][Full Text] [Related]
7. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury. Mangat HS; Chiu YL; Gerber LM; Alimi M; Ghajar J; Härtl R J Neurosurg; 2015 Jan; 122(1):202-10. PubMed ID: 25380107 [TBL] [Abstract][Full Text] [Related]
8. The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy. Olivecrona M; Koskinen LO Acta Neurochir (Wien); 2012 Sep; 154(9):1567-73. PubMed ID: 22543506 [TBL] [Abstract][Full Text] [Related]
9. Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen-directed therapy. Narotam PK; Morrison JF; Nathoo N J Neurosurg; 2009 Oct; 111(4):672-82. PubMed ID: 19463048 [TBL] [Abstract][Full Text] [Related]
10. Traditional systolic blood pressure targets underestimate hypotension-induced secondary brain injury. Brenner M; Stein DM; Hu PF; Aarabi B; Sheth K; Scalea TM J Trauma Acute Care Surg; 2012 May; 72(5):1135-9. PubMed ID: 22673237 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of brain tissue changes induced by traumatic brain injury assessed with the Marshall, Morris-Marshall, and the Rotterdam classifications and its impact on outcome in a prostacyclin placebo-controlled study. Bobinski L; Olivecrona M; Koskinen LO Acta Neurochir (Wien); 2012 Jun; 154(6):1069-79. PubMed ID: 22538327 [TBL] [Abstract][Full Text] [Related]